Trace Elements and Bone Metabolism

  • Anne Peretz


The role of trace elements (TE) in bone has been mostly investigated for diagnostic procedures (isotopic scans, absorption test, fossil analysis) because they are bone-seekers that concentrate at the surface of bone. The presence of essential TE at physiological levels represents a reservoir (zinc, copper) while the presence of other elements which are environmental contaminants may be toxic for bone. Analysis of human skeletons from prehistoric to present time (1) revealed that TE concentrations vary with time and geographic situation. For example, bone lead concentration increased dramatically in Europe from prehistoric to middle-age, followed by a decrease until present period which seems in contradiction with the industry burst observed in our countries. The analysis of TE concentrations in bone for clinical or research purposes is a complicated task because reference data are lacking for “normal trace elements concentrations” in human bone biopsy. Very few authors (2) analysed human iliac crest bone for their bulk and trace elements in healthy and osteoporotic subjects.


Bone Resorption Zinc Sulfate Zinc Salt Menkes Disease Gallium Nitrate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A. Chausmer, S. Wallach, in Trace Metals and Fluoride in Bones and Teeth, N.D. Priest, F.L. Van De Vyver, eds, CRC Press, Boca Raton, Floride, pp 253–270 (1990).Google Scholar
  2. 2.
    M. F. Baslé, Y. Mauras, M. Audran, P. Clochon, A. Rebel, P. Allain, J. Bone Miner. Res. 1, 41–47 (1990).CrossRefGoogle Scholar
  3. 3.
    G.R. Mundy, Bone remodeling and its disorders, Martin Dunitz Ltd, London (1995).Google Scholar
  4. 4.
    L. Strause, P. Saltman, K. Smith, M. Andon, inNutritional Aspects of Osteoporosis, vol. 85, P. Burckhardt, R.P. Heaney, eds, Raven Press, New York, pp. 223–233 (1991).Google Scholar
  5. 5.
    R. E. Burch, H.K.J. Hahn, J.F. Sullivan, Clin. Chim. 21, 501–520 (1975).Google Scholar
  6. 6.
    M. Yamaguchi, R. Yamaguchi, Biochem. Pharmacol. 35, 773–777 (1986).CrossRefGoogle Scholar
  7. 7.
    M. Yamaguchi, J. Ohtaki, Pharmacology 43, 225–232 (1991).CrossRefGoogle Scholar
  8. 8.
    M. Yamaguchi, S. Kishi, M. Hashisume, osteoblastic MC3T3-E 1 cells: activation Peptides 15, 1367–1371 (1994).CrossRefGoogle Scholar
  9. 9.
    T. Matsui, M. Yamaguchi, Peptides 16, 1063–1068 (1995).CrossRefGoogle Scholar
  10. 10.
    S. Kishi, M. Yamaguchi, Biochem. Pharmacol. 48, 1225–1230 (1994).CrossRefGoogle Scholar
  11. 11.
    B. Moonga, D.W. Dempster, J. Bone Miner. Res. 10, 453–457 (1995).CrossRefGoogle Scholar
  12. 12.
    Y Segawa, N. Tsuzuike, E. Tagashira, M. Yamaguchi, Biol. Pharm. Bull. 16, 486–489 (1991).CrossRefGoogle Scholar
  13. 13.
    Y Segawa, N. Tsuzuike, Y Itokazu, E. Tagashira, M. Yamaguchi, Res. Exp. Med. 192, 317–322 (1992).CrossRefGoogle Scholar
  14. 14.
    E.M. Alhava, H. Olkkonen, J. Puittinen, V.M. Nokko-Koivisto, Acta Orthop. Scand. 48, 1–4 (1977).CrossRefGoogle Scholar
  15. 15.
    J. Yoshinaga, T. Suzuki, M. Morita, M. Hayakawa, Sci. Total Environ. 162, 239–252 (1995).CrossRefGoogle Scholar
  16. 16.
    A. Ohry, Y Shemesh, R. Zak, M. Herzberg, Paraplegia 18, 174–180 (1980).CrossRefGoogle Scholar
  17. 17.
    M. Herzberg, J. Foldes, R. Steinberg, J. Menczel, J. Bone Miner. Res. 5, 251–257 (1990).CrossRefGoogle Scholar
  18. 18.
    J.J. Strain, Med Hypotheses 27, 332–338 (1988).CrossRefGoogle Scholar
  19. 19.
    J.Y Reginster, L.G. Strause, P. Saltman, P. Franchimont, Med. Sci. Res. 16, 337–338 (1988).Google Scholar
  20. 20.
    S. Sasaki, H. Iwata, N. Lshiguro, O. Habuchi, T. Miura, bone, and articular Nutrition 10, 538–543 (1994).Google Scholar
  21. 21.
    C. Yang, C. Niu, M. Bodo, E. Gabriel, H. Notbohm, E. Wolf, P.K. Müller, acid Biochem. J. 289, 829–835 (1993).Google Scholar
  22. 22.
    M.J. Keenan, M. Hegsted, P.J. Wozniak, J. D. Bott, A. Reisenauer, colonies. J. Vit. Nutr. Res. 62, 228–232 (1992).Google Scholar
  23. 23.
    P.E. Keeting, M.J. Oursler, K.E. Wiegand, S.K. Bonde, T.C. Spelsberg, B.L. Riggs, J. Bone Miner. Res. 7, 1281–1289(1992).CrossRefGoogle Scholar
  24. 24.
    N. Schütze, M.J. Oursler, J. Nolan, B.L. Riggs, Spelsberg, J. Cell. Biochem. 58, 39–46 (1995).CrossRefGoogle Scholar
  25. 25.
    P.T. Guidon, J.R. Roberto Salvatori, R. Bockman, J. Bone Miner. Res. 8, 103–112 (1993).CrossRefGoogle Scholar
  26. 26.
    R.E. Newnham, Environ. Health Perspect. 102 (suppl 7), 83–85 (1994).Google Scholar
  27. 27.
    S.L. Meacham, L.J. Taper, S. L. Volpe, Environ. Health Perspect. 102 (suppl 7), 79–82 (1994).Google Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Anne Peretz
    • 1
  1. 1.Rheumatology Clinic, Internal Medicine DepartmentHôpital Universitaire BrugmannBrusselsBelgium

Personalised recommendations